US Map / Mississippi

State MS

Clinical Trials in Mississippi

Recruiting clinical trials with at least one study location in Mississippi. Data updated daily from ClinicalTrials.gov.

Total Trials

58

Recruiting Now

58

← Back to US Map

Top Conditions in Mississippi

Malignant Solid Neoplasm (3)Lung Non-Small Cell Carcinoma (2)Breast Carcinoma (1)Colorectal Carcinoma (1)Melanoma (1)Non-Hodgkin Lymphoma (1)Adrenal Gland Pheochromocytoma (1)Carcinoma In Situ (1)Central Nervous System Neoplasm (1)Childhood Immature Teratoma (1)Childhood Kidney Neoplasm (1)Childhood Langerhans Cell Histiocytosis (1)

NCT06418204 N/A

Recruiting

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...

United States, Puerto Rico

Sponsor

Wake Forest University Health

View Trial →

NCT02402244 N/A

Recruiting

Project: Every Child for Younger Patients With Cancer

Condition

Adrenal Gland Pheochromocytoma

Enrollment

75,000 pts

Location

United States, Australia, Canada

Sponsor

Children's Oncology Group

View Trial →

NCT05339139 Phase 3

Recruiting

SAfety of Regional Citrate Anticoagulation (SARCA Study)

Fresenius Medical Care North A

View Trial →

NCT06937229 Phase 3

Recruiting

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agi...

United States, Argentina, Brazil

Low Systemic/High Local Exercise Load in Peds SCD

Condition

Sickle Cell Anemia in Children

University of Mississippi Medi

View Trial →

NCT06513962 Phase 3

Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...

Condition

Hematopoietic and Lymphatic System Neoplasm

Enrollment

60 pts

Location

United States, Canada

Sponsor

Children's Oncology Group

View Trial →

NCT06307652 Phase 3

Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...

Condition

Heart Failure and Impaired Kidney Function

Enrollment

4,800 pts

Location

United States, Argentina, Australia

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...

Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...

Condition

Proteinuric Kidney Disease

Vertex Pharmaceuticals Incorpo

View Trial →

NCT06091254 Phase 3

Recruiting

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Work...

Condition

Follicular Lymphoma (FL)

Enrollment

822 pts

Location

United States, Australia, Austria

Sponsor

Regeneron Pharmaceuticals

View Trial →

NCT05843903 N/A

Recruiting

Teen Mom Study Feasibility Trial

University of Mississippi Medi

View Trial →

NCT07116746 Phase 2

Recruiting

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase ...

Arthrosi Therapeutics

View Trial →

NCT07037433 Phase 3

Recruiting

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...

Condition

Atherosclerotic Cardiovascular Disease

Enrollment

12,800 pts

Location

United States, Argentina, Australia

A Mobile Gaming App to Improve Adherence to PrEP

Rhode Island Hospital

View Trial →

NCT07145229 Phase 2

Recruiting

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Condition

Acute Gouty Arthritis

Enrollment

380 pts

Location

United States, Australia, China

Sponsor

Atom Therapeutics Co., Ltd

View Trial →

NCT05803941 Phase 4

Recruiting

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...

United States, Austria, Belgium

Sponsor

Novartis Pharmaceuticals

View Trial →

NCT07104383 Phase 3

Recruiting

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

United States, Puerto Rico

Sponsor

Viking Therapeutics, Inc.

View Trial →

NCT05237466 N/A

Recruiting

Motivational Interviewing to Enhance Behavioral Change in Older Adults with Hoar...

Mississippi State University

View Trial →

NCT06662786 Phase 3

Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...

United States, Belgium, Brazil

Sponsor

Janssen Research & Development

View Trial →

NCT04293562 Phase 3

Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...

Condition

Acute Myeloid Leukemia

Enrollment

1,186 pts

Location

United States, Australia, Canada

Sponsor

Children's Oncology Group

View Trial →

NCT05354141 Phase 3

Recruiting

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...

Condition

Acute Respiratory Distress Syndrome

Direct Biologics, LLC

View Trial →

NCT05040360 Phase 2

Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...

Condition

Metastatic Malignant Neoplasm in the Liver

Enrollment

141 pts

Location

United States, Mexico, Uruguay

Sponsor

SWOG Cancer Research Network

View Trial →

NCT06149286 Phase 3

Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works...

Condition

Relapsed/Refractory Follicular Lymphoma

Enrollment

470 pts

Location

United States, Australia, Austria

Sponsor

Regeneron Pharmaceuticals

View Trial →

NCT07283939 N/A

Recruiting

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...

Condition

Ampulla of Vater Carcinoma

Alliance for Clinical Trials i

View Trial →

NCT06295367 N/A

Recruiting

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Condition

Malignant Solid Neoplasm

Enrollment

760 pts

Location

United States, Puerto Rico

Sponsor

ECOG-ACRIN Cancer Research Gro

View Trial →

Page 1 of 3 — 58 trials total